Mosapride Citrate Injection(Shandong New Time Pharma)

枸橼酸莫沙必利注射液(山东新时代药业)

Report date: 2025/08/27 20:01:50

Base Information

Drug NameMosapride Citrate Injection(Shandong New Time Pharma)
Drug Alias Namemosapride莫沙必利枸橼酸盐Mosafe莫沙比利枸橼酸盐mosapridum +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsGastrointestinal motility disordersPostoperative ComplicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGastrointestinal motility disordersPostoperative ComplicationsGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG